SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-15-352159
Filing Date
2015-10-23
Accepted
2015-10-23 17:19:00
Documents
2
Group Members
QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d53315dsc13g.htm SC 13G 70072
2 EXHIBIT A d53315dex99a.htm EX-99.A 9077
  Complete submission text file 0001193125-15-352159.txt   80840
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86177 | Film No.: 151173461
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G